RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.

Preeclampsia (PE) is a placentally-induced hypertensive disorder of pregnancy that is associated with significant morbidity and mortality to mothers and fetuses. Clinical manifestations of preterm PE result from excess circulating soluble vascular endothelial growth factor receptor FLT1 (sFLT1 or sV...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Biotechnol
Auteurs principaux: Turanov, Anton A., Lo, Agnes, Hassler, Matthew R., Makris, Angela, Ashar-Patel, Ami, Alterman, Julia F., Coles, Andrew H., Haraszti, Reka A., Roux, Loic, Godinho, Bruno MDC, Echeverria, Dimas, Pears, Suzanne, Iliopoulos, Jim, Shanmugalingam, Renuka, Ogle, Robert, Zsengeller, Zsuzsanna K., Hennessy, Annemarie, Karumanchi, S. Ananth, Moore, Melissa J., Khvorova, Anastasia
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526074/
https://ncbi.nlm.nih.gov/pubmed/30451990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4297
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires